International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") today reported fourth quarter and fiscal year 2024 results. For the fourth quarter, revenues were $3,901,625, an increase of ...

IDAHO FALLS, Idaho, Jan. 9, 2025 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) ("International Isotopes," "INIS" or the "Company") is pleased to announce that it has amended and ...

Sale of product for first quarter increased 12% to $3.2 million. <li /> Nuclear Medicine Standards sale of product in the first quarter i ...

Morningstar brands and products Company Portfolio ...

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical ...

ASP Isotopes Inc. (NASDAQ:ASPI) announced entering an agreement for the potential acquisition of Renergen Limited to create ...

IDAHO FALLS, Idaho and MADISON, Wis., Sept. 4, 2024 /PRNewswire/ -- International Isotopes, Inc. (INIS) and Phantech Medical (Phantech) have entered into a joint venture agreement to form PhanQual ...

Shahe Bagerdjian, President and CEO of International Isotopes Inc. (OTC:INIS), has acquired 100,000 shares of the company's common stock, according to a recent SEC filing. The transaction, which ...

International Isotopes Inc manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing ...

IDAHO FALLS, Idaho, May 20, 2025 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") is pleased to announce it's first quarter 2025 results. For the first quarter ...

IDAHO FALLS, Idaho, Jan. 13, 2025 /PRNewswire/ -- International Isotopes, Inc. (INIS) ("International Isotopes," "INIS" or the "Company"), is excited to announce a ...